These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18085398)

  • 1. What does the circulating AHSG/fetuin-A level tell us?
    Kazama JJ
    Clin Exp Nephrol; 2007 Dec; 11(4):336-337. PubMed ID: 18085398
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis.
    Oikawa O; Higuchi T; Yamazaki T; Yamamoto C; Fukuda N; Matsumoto K
    Clin Exp Nephrol; 2007 Dec; 11(4):304-308. PubMed ID: 18085392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum fetuin-A and biochemical parameters in hemodialysis patients.
    Haddad M; Tajbakhsh R; Farajollahi M; Qorbani M; Besharat S; Joshaghani HR
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):769-73. PubMed ID: 24969186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fetuin-A levels following treatment with a vitamin D analog.
    Manenti L; Vaglio A; Pasquali S
    Kidney Int; 2010 Dec; 78(11):1187; author reply 1187-9. PubMed ID: 21076451
    [No Abstract]   [Full Text] [Related]  

  • 5. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.
    Stenvinkel P; Wang K; Qureshi AR; Axelsson J; Pecoits-Filho R; Gao P; Barany P; Lindholm B; Jogestrand T; Heimbürger O; Holmes C; Schalling M; Nordfors L
    Kidney Int; 2005 Jun; 67(6):2383-92. PubMed ID: 15882283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation.
    Rambod M; Kovesdy CP; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1691-701. PubMed ID: 18922994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
    Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
    Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BNP in hemodialysis patients.
    Parfrey PS
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):954-5. PubMed ID: 20507956
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.
    Ketteler M; Bongartz P; Westenfeld R; Wildberger JE; Mahnken AH; Böhm R; Metzger T; Wanner C; Jahnen-Dechent W; Floege J
    Lancet; 2003 Mar; 361(9360):827-33. PubMed ID: 12642050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum fetuin-A and aortic calcification in hemodialysis patients.
    Odamaki M; Shibata T; Takita T; Kumagai H
    Kidney Int; 2005 Dec; 68(6):2915; author reply 2916. PubMed ID: 16316382
    [No Abstract]   [Full Text] [Related]  

  • 11. Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach.
    Verduijn M; Prein RA; Stenvinkel P; Carrero JJ; le Cessie S; Witasp A; Nordfors L; Krediet RT; Boeschoten EW; Dekker FW
    Nephrol Dial Transplant; 2011 Jan; 26(1):239-45. PubMed ID: 20605840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease.
    Suliman ME; García-López E; Anderstam B; Lindholm B; Stenvinkel P
    Adv Clin Chem; 2008; 46():217-62. PubMed ID: 19004191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of an immunoluminometric assay (ILMA) for fetuin-A-glycoprotein.
    Bäumer A; Schmidt-Gayk H; Aulmann M; Kim TS
    J Immunoassay Immunochem; 2010; 31(1):10-23. PubMed ID: 20391014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23: fashion or physiology?
    Wolf M
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1727-9. PubMed ID: 20847097
    [No Abstract]   [Full Text] [Related]  

  • 15. Fetuin-A and extraosseous calcification in uremia.
    Ketteler M
    Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):337-42. PubMed ID: 15931001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels.
    Osawa M; Tian W; Horiuchi H; Kaneko M; Umetsu K
    Hum Genet; 2005 Feb; 116(3):146-51. PubMed ID: 15592877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of new comorbidities on nutritional status in continuous ambulatory peritoneal dialysis patients.
    Dong J; Wang T; Wang HY
    Blood Purif; 2006; 24(5-6):517-23. PubMed ID: 17077624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients.
    Cozzolino M; Galassi A; Biondi ML; Turri O; Papagni S; Mongelli N; Civita L; Gallieni M; Brancaccio D
    Am J Nephrol; 2006; 26(5):423-9. PubMed ID: 16968979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human alpha 2-HS-glycoprotein/bovine fetuin homologue in mice: identification and developmental regulation of the gene.
    Yang F; Chen ZL; Bergeron JM; Cupples RL; Friedrichs WE
    Biochim Biophys Acta; 1992 Mar; 1130(2):149-56. PubMed ID: 1373325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of fetuin-A and cardiac calcification and inflammation levels in hemodialysis patients.
    El-Shehaby AM; Zakaria A; El-Khatib M; Mostafa N
    Scand J Clin Lab Invest; 2010 Dec; 70(8):575-82. PubMed ID: 20964498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.